Activation of AMP-activated protein kinase reduces collagen production via p38 MAPK in cardiac fibroblasts induced by coxsackievirus B3

Jiang,Shengyang; Jiang,Donglin; Zhao,Peng; He,Xinlong; Tian,Shunli; Wu,Xueming; Tao,Yijia

doi:10.3892/mmr.2016.5319

Activation of AMP-activated protein kinase reduces collagen production via p38 MAPK in cardiac fibroblasts induced by coxsackievirus B3

Authors:
- Shengyang Jiang
- Donglin Jiang
- Peng Zhao
- Xinlong He
- Shunli Tian
- Xueming Wu
- Yijia Tao
View Affiliations

Affiliations: Department of Cardiology, The Third Affiliated Hospital of Nantong University, Wuxi Institute of Integrated Traditional Chinese and Western Medicine, Wuxi, Jiangsu 214041, P.R. China, Clinical Central Laboratory, The Third Affiliated Hospital of Nantong University, Wuxi Institute of Integrated Traditional Chinese and Western Medicine, Wuxi, Jiangsu 214041, P.R. China, Department of Geratology, Tianjin Geriatric Institute, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China
Published online on: May 20, 2016 https://doi.org/10.3892/mmr.2016.5319
Pages: 989-994

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Collagen deposition is the major cause of myocardial fibrosis, contributing to impaired cardiac contractile function in coxsackie virus B3 (CVB3)-infected hearts. Adenosine monophosphate-activated protein kinase (AMPK) has been considered as a cellular fuel gauge and super metabolic regulator, however, whether AMPK has an effect on collagen production in CVB3‑infected heart remains to be elucidated. In the present study, the association between AMPK activation and CVB3‑infected neonatal rat cardiac fibroblasts (NRCFs) was investigated. Collagen production was determined by the hydroxyproline content of the supernatant and by the expression of type I/IV collagen in the cell lysate. Rat hydroxyproline ELISA was used to detect hydroxyproline content in the supernatant. The expression of type I/IV collagen, and the phosphorylation of AMPKα‑Thr172 and p38 in the cell lysate were evaluated using western blotting. As expected, it was found that the hydroxyproline content in the supernatant, and the production of collagen I/IV in the cell lysate were significantly promoted at 48 h post‑CVB3‑infection. However, this effect was inhibited in a dose‑dependent manner when pretreated with 5‑aminoimidazole‑4‑carboxamide‑1‑4‑ribofuranoside (AICAR) for 2 h prior to CVB3‑infection. However, if the cells were preincubated with compound C or SB203580 for 30 min prior the treatment with AICAR, the inhibitive effects of AICAR were reversed. The results of the western blotting indicated that the phosphorylation of AMPKα‑Thr172 and p38 were significantly increased by AICAR in the NRCFs. However, only the phosphorylation of p38 mitogen‑activated protein kinase (MAPK) was inhibited by SB203580. In conclusion, AMPK activation reduced collagen production via the p38 MAPK‑dependent pathway in the cardiac fibroblasts induced by CVB3. The results of the present study may contribute to identifying an effective therapy for CVB3‑induced myocarditis and CVB3-associated dilated cardiomyopathy.

View Figures

View References

1	Ellis CR and Di Salvo T: Myocarditis: Basic and clinical aspects. Cardiol Rev. 15:170–177. 2007. View Article : Google Scholar : PubMed/NCBI
2	Magnani JW and Dec GW: Myocarditis: Current trends in diagnosis and treatment. Circulation. 113:876–890. 2006. View Article : Google Scholar : PubMed/NCBI
3	Sagar S, Liu PP and Cooper LT Jr: Myocarditis. Lancet. 379:738–747. 2012. View Article : Google Scholar
4	Eghbali M: Cardiac fibroblasts: Function, regulation of gene expression and phenotypic modulation. Basic Res Cardiol. 87(Suppl 2): S183–S189. 1992.
5	Lindner D, Li J, Savvatis K, Klingel K, Blankenberg S, Tschöpe C and Westermann D: Cardiac fibroblasts aggravate viral myocarditis: Cell specific coxsackievirus B3 replication. Mediators Inflamm. 2014:5195282014. View Article : Google Scholar : PubMed/NCBI
6	Cao Y, Xu W and Xiong S: Adoptive transfer of regulatory T cells protects against Coxsackievirus B3-induced cardiac fibrosis. PLoS One. 8:e749552013. View Article : Google Scholar : PubMed/NCBI
7	Swaney JS, Roth DM, Olson ER, Naugle JE, Meszaros JG and Insel PA: Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc Natl Acad Sci USA. 102:437–442. 2005. View Article : Google Scholar :
8	Zaha VG and Young LH: AMP-activated protein kinase regulation and biological actions in the heart. Circ Res. 111:800–814. 2012. View Article : Google Scholar : PubMed/NCBI
9	Horman S, Beauloye C, Vanoverschelde JL and Bertrand L: AMP-activated protein kinase in the control of cardiac metabolism and remodeling. Curr Heart Fail Rep. 9:164–173. 2012. View Article : Google Scholar : PubMed/NCBI
10	Xie W, Wang L, Dai Q, Yu H, He X, Xiong J, Sheng H, Zhang D, Xin R, Qi Y, et al: Activation of AMPK restricts coxsackievirus B3 replication by inhibiting lipid accumulation. J Mol Cell Cardiol. 85:155–167. 2015. View Article : Google Scholar : PubMed/NCBI
11	Reed LJ and Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg. 27:493–497. 1938.
12	Yu XY, Qiao SB, Guan HS, Liu SW and Meng XM: Effects of visfatin on proliferation and collagen synthesis in rat cardiac fibroblasts. Horm Metab Res. 42:507–513. 2010. View Article : Google Scholar : PubMed/NCBI
13	Liu PP and Yan AT: Cardiovascular magnetic resonance for the diagnosis of acute myocarditis: Prospects for detecting myocardial inflammation. J Am Coll Cardiol. 45:1823–1825. 2005. View Article : Google Scholar : PubMed/NCBI
14	Pchejetski D, Foussal C, Alfarano C, Lairez O, Calise D, Guilbeau-Frugier C, Schaak S, Seguelas MH, Wanecq E, Valet P, et al: Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1. Eur Heart J. 33:2360–2369. 2012. View Article : Google Scholar
15	Leipner C, Grün K, Müller A, Buchdunger E, Borsi L, Kosmehl H, Berndt A, Janik T, Uecker A, Kiehntopf M and Böhmer FD: Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis. Cardiovasc Res. 79:118–126. 2008. View Article : Google Scholar : PubMed/NCBI
16	Yu M, Hu J, Zhu MX, Zhao T, Liang W, Wen S, Li HH, Long Q, Wang M, Guo HP, et al: Cardiac fibroblasts recruit Th17 cells infiltration into myocardium by secreting CCL20 in CVB3-induced acute viral myocarditis. Cell Physiol Biochem. 32:1437–1450. 2013. View Article : Google Scholar : PubMed/NCBI
17	Bhattacharjee A and Bansal M: Collagen structure: The Madras triple helix and the current scenario. IUBMB Life. 57:161–172. 2005. View Article : Google Scholar : PubMed/NCBI
18	Kasyanov V, Moreno-Rodriguez RA, Kalejs M, Ozolanta I, Stradins P, Wen X, Yao H and Mironov V: Age-related analysis of structural, biochemical and mechanical properties of the porcine mitral heart valve leaflets. Connect Tissue Res. 54:394–402. 2013. View Article : Google Scholar : PubMed/NCBI
19	Puthanveetil P, Wang F, Kewalramani G, Kim MS, Hosseini-Beheshti E, Ng N, Lau W, Pulinilkunnil T, Allard M, Abrahani A and Rodrigues B: Cardiac glycogen accumulation after dexamethasone is regulated by AMPK. Am J Physiol Heart Circ Physiol. 295:H1753–H1762. 2008. View Article : Google Scholar : PubMed/NCBI
20	Liu WY and Jiang RS: Advances in the research of AMPK and its subunit genes. Pak J Biol Sci. 16:1459–1468. 2013. View Article : Google Scholar
21	Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, Jing C, Walker PA, Eccleston JF, Haire LF, et al: Structure of mammalian AMPK and its regulation by ADP. Nature. 472:230–233. 2011. View Article : Google Scholar : PubMed/NCBI
22	Baron SJ, Li J, Russell RR III, Neumann D, Miller EJ, Tuerk R, Wallimann T, Hurley RL, Witters LA and Young LH: Dual mechanisms regulating AMPK kinase action in the ischemic heart. Circ Res. 96:337–345. 2005. View Article : Google Scholar : PubMed/NCBI
23	Novikova DS, Garabadzhiu AV, Melino G, Barlev NA and Tribulovich VG: AMP-activated protein kinase: Structure, function, and role in pathological processes. Biochemistry (Mosc). 80:127–144. 2015. View Article : Google Scholar
24	Kar R, Kellogg DL III and Roman LJ: Oxidative stress induces phosphorylation of neuronal NOS in cardiomyocytes through AMP-activated protein kinase (AMPK). Biochem Biophys Res Commun. 459:393–397. 2015. View Article : Google Scholar : PubMed/NCBI
25	Kang S, Chemaly ER, Hajjar RJ and Lebeche D: Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways. J Biol Chem. 286:18465–18473. 2011. View Article : Google Scholar : PubMed/NCBI
26	Du JH, Xu N, Song Y, Xu M, Lu ZZ, Han C and Zhang YY: AICAR stimulates IL-6 production via p38 MAPK in cardiac fibroblasts in adult mice: A possible role for AMPK. Biochem Biophys Res Commun. 337:1139–1144. 2005. View Article : Google Scholar : PubMed/NCBI
27	Ma Y, Wang J, Gao J, Yang H, Wang Y, Manithody C, Li J and Rezaie AR: Antithrombin up-regulates AMP-activated protein kinase signalling during myocardial ischaemia/reperfusion injury. Thromb Haemost. 113:338–349. 2015. View Article : Google Scholar
28	Li Y, Chen C, Yao F, Su Q, Liu D, Xue R, Dai G, Fang R, Zeng J, Chen Y, et al: AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1. Arch Biochem Biophys. 558:79–86. 2014. View Article : Google Scholar : PubMed/NCBI
29	Jiang SY, Xu M, Ma XW, Xiao H and Zhang YY: A distinct AMP-activated protein kinase phosphorylation site characterizes cardiac hypertrophy induced by L-thyroxine and angiotensin II. Clin Exp Pharmacol Physiol. 37:919–925. 2010. View Article : Google Scholar : PubMed/NCBI
30	Beauloye C, Bertrand L, Horman S and Hue L: AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Cardiovasc Res. 90:224–233. 2011. View Article : Google Scholar : PubMed/NCBI
31	Yamazaki KG, Gonzalez E and Zambon AC: Crosstalk between the renin-angiotensin system and the advance glycation end product axis in the heart: Role of the cardiac fibroblast. J Cardiovasc Transl Res. 5:805–813. 2012. View Article : Google Scholar : PubMed/NCBI